Harm Reduction—From a Conceptual Framework to Practical Experience: The Example of Germany

REFERENCES

• American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (DSM-IV) (4th ed.). Washington, DC: Author.
   Google Scholar
• Backmund, M. (2007). Suchttherapie. Grundlagen, Klinik, Standards (12th ed.) [Addiction therapy. Basic knowledge, clinic, standards]. Munich: Ecomed.
   Google Scholar
• Böllinger, L., & Stöver, H. (2002). Drogenrecht, Drogenpraxis, Drogenpolitik [Drug laws, drug reality and drug policy]. Frankfurt am Main: Fachhochschulverlag.
   Google Scholar
• Bossong, H. (1991). Kritische Bestandsaufnahme zur aktuellen Drogenpolitik. Werkstattgespräche Drogenpolitik [Critical review on current drug policy. Workshop talk on drug policy]. Bonn: Juso-Bundesvorstand.
   Google Scholar
• Bschor, F. (1983). Mortality of drug dependent patients in international comparison. Lebensversicherungs Medizin, 35, 74–80.
   PubMedGoogle Scholar
• Bühringer, G. (2006). Allocating treatment options to patients profiles: clinical art or science? Addiction, 101, 646–652.
   PubMed Web of Science ®Google Scholar
• Bundesärztekammer. (2010, March 19). Richtlinien der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opiatabhängiger [Guidelines of the Federal Chamber of Medical Doctors for implementation of substitution-assisted treatment of opiate dependents] (Vol. 107, pp. A511–B516). Berlin: Deutsches Ärzteblatt.
   Google Scholar
• Buscema, M. (1998). Artificial neural networks. Substance Use & Misuse, 33, 1–3.
   Web of Science ®Google Scholar
• Commission of the European Communities. (2007, April 18). Report from the Commission to the European Parliament and the Council on the implementation of the Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence [Doc. No. COM(2007) 199 final] Brussels.
   Google Scholar
• Degkwitz, P., Chorzelski, G., & Krausz, M. (1993, July 1–2). Five years of methadone prescription in Germany. In M. Reisinger (Ed.), Aids and drug addiction in the European community (pp. 81–89), Proceedings of a Seminar on AIDS and Drug Addiction in the Twelve European Communities Member States. Brussels: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
   Google Scholar
• Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., Mcdonald, D., & Trautmann, F. (2000). Drug consumption facilities in Europe and the establishment of supervised injecting centers in Australia. Drug and Alcohol Review, 19, 337–346.
   Web of Science ®Google Scholar
• Gerlach, R. (2002). Drug substitution treatment in Germany: a critical overview of its history, legislation and current practice. Journal on Drug Issues, 2, 503–522.
   Google Scholar
• Gölz, J. (1998). Moderne Suchtmedizin [Modern addiction medicine]; Stuttgart/New York: Thieme.
   Google Scholar
• Haasen, C. (2011). The German model project for heroin assisted treatment of opioid dependent patients –a multi centre, randomized, controlled trial. Retrieved March 31, 2011, from http://www.heroinstudie.de/Summ_German_H-Study.pdf
   Google Scholar
• Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2006). Heroin-assisted treatment for opioid dependence—a randomised, controlled clinical trial (Report to the Federal Ministry of Health). Berlin: Federal Ministry of Health.
   Google Scholar
• Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence: randomised controlled trial. British Journal of Psychiatry, 191, 55–62.
   PubMed Web of Science ®Google Scholar
• Hedrich, D. (2004). European report on drug consumption rooms. Lisbon: European Monitoring Center of Drugs and Drug Addiction.
   Google Scholar
• Hedrich, D., Kerr Th., & Dubois-Arber, F. (2010). Drug consumption facilities in Europe and beyond. In T. Rhodes & D. Hedrich (Eds.), Harm reduction: evidence, impacts and challenges (pp. 305–332). Lisbon: EMCDDA Monographs.
   Google Scholar
• Kastelic, A., Pont, J., & Stöver, H. (2008). Opioid substitution treatment in custodial settings: a practical guide. Oldenburg: WHO/UNODC.
   Google Scholar
• Kimber, J., Dolan, K., van Beek, I., Hedrich, D., & Zurhold, H. (2003). Drug consumption facilities: an update since 2000. Drug and Alcohol Review, 22, 227–233.
   PubMed Web of Science ®Google Scholar
• Kimber, J., Dolan, K., & Wodak, A. (2002). International survey of supervised injecting centres (1999–2000). Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Kleiber, D., & Pant, A. (1996). HIV-needle-sharing-sex. Bonn: Federal Ministry of Health.
   Google Scholar
• Körner, H. H. (1993, May). Strafrechtliches Gutachten zur Zulässigkeit von Gesundheitsräumen für den hygienischen und stressfreien Konsum von Opiatabhängigen [Penal expertise on legitimacy of healthy rooms for hygenic and stress-free consumption of opiate dependents]. Wiesbaden: Zentralstelle zur Bekämpfung der Betäubungsmittelkriminlität.
   Google Scholar
• Krach, C., Lotze, J., Peschke, H., Peter, U., Rabe, M. L., Schönhofer, P. (1978). Ambulantes Therapieprogramm mit Methadon [Out-patient therapy program with Methadone]. Niedersächsisches Ärzteblatt, 51, 289–293.
   Google Scholar
• Kraus, L., & Pabst, A. (2010). Epidemiologischer Suchtsurvey 2009 [Epidemiological survey on substance abuse]. Sucht, 56(5), 309–384.
   Google Scholar
• Krausz, M., Verthein, U., Degkwitz, P., Haasen, C., & Raschke, P. (1998). Maintenance treatment of opiate addicts in Germany with medications containing codeine—results of a follow-up study. Addiction, 93, 1161–1167.
   PubMed Web of Science ®Google Scholar
• Michels, I. I. (1993, July 1–2). Critical analysis of the drug treatment policy in Germany. In M. Reisinger (Ed.), Aids and drug addiction in the European community. Proceedings of a Seminar on AIDS and Drug Addiction in the Twelve European Communities Member States, Brussels. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
   Google Scholar
• Michels, I. I. (2002). Heroin based treatment. Journal on Drug Issues, 2, 523–542.
   Google Scholar
• Michels, I. I. (2005). Substitutionsbehandlungen in Deutschland —vom Tal der Tränen in die Mühen der Ebene [Substitution treatment in Germany –from the valley of tears to the hardship of the plain]. In R. Gerlach & H. Stöver (Eds.), Vom Tabu zur Normalität. 20 Jahre Substitution in Deutschland. Zwischenbilanz und Aufgaben für die Zukunft. Freiburg i.Br.: Lambertus.
   Google Scholar
• Michels, I. I., Sander, G., & Stöver, H. (2009). Praxis, Probleme und Perspektiven der Substitutionsbehandlung Opioidabhängiger in Deutschland [Practice, problems and perspectives of substitution treament for opioid dependents]. Bundesgesundheitsblatt— Gesundheitsforschung—Gesundheitsschutz, 52, 111–121.
   PubMedGoogle Scholar
• Michels, I., Stöver, H., & Gerlach, R. (2007). Substitution treatment for opioid dependents in Germany. International Journal of Harm Reduction, 4, 5.
   PubMedGoogle Scholar
• Michels, I. I., Stöver, H., & Schuller, K. (1990, April 9–12). The availability of sterile syringes in the Federal Republic of Germany. Paper presented on the 1st International Conference on the Reduction of Drug Related Harm, Liverpool, England.
   Google Scholar
• Ministerium NRW (Ministerium für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen) (Ed.). (1998). Medikamentengestützte Rehabilitation i.v. Opiatabhängiger— Katamnese [Medication-supported rehabilitation of i.v. drug addicts—follow-up]. Düsseldorf: Author.
   Google Scholar
• Newcombe, R. (1992). The reduction of drug related harm: a conceptual framework fort theory, practice and research. (pp. 1–14) In P. O'Hare, (Eds.), The reduction of drug related harm. London and New York.
   Google Scholar
• Newman, R. G. (1988). Is there a role for methadone in Germany? AIDS & Public Policy Journal, 3, 23–29.
   PubMedGoogle Scholar
• Newman, R. G. (1995). Another wall that crumbled—methadone maintenance treatment in Germany. American Journal of Drug & Alcohol Abuse, 21, 27–35.
   PubMed Web of Science ®Google Scholar
• Pabst, A., Piontek, D., Kraus, L., & Müller, S. (2010). Substanzkonsum und substanzbezogene Störungen. Ergebnisse des Epidemiologischen Suchtsurveys 2009 [Substance use and substance use disorders. Results of the 2009 Epidemiological Survey of Substance Abuse]. Sucht, 56(5), 327–336.
   Google Scholar
• Pfeiffer-Gerschel, T., & Simon, R. (2008). Cannabisbezogene Störungen - Neue Ansätze in Prävention und Behandlung. Sucht, 54(4), 229–233.
   Google Scholar
• Pfeiffer-Gerschel, T., Kipke, I., Flöter, S., Jakob, L., Hammes, D., & Raiser, P. (2011). Deutschland. Drogensituation 2010/2011. Neue Entwicklungen, Trends und Hintergrundinformationen zu Schwerpunktthemen [Germany. Drug situation 2010/2011. New developments, trends and in-depth information on selected issues]. Munich: Institute for Therapy Research.
   Google Scholar
• Poschadel, S., Höger, R., Schnitzler, J., & Schreckenberg, D.,(2003). Evaluation der Arbeit der Drogenkonsumräume in der Bundesrepublik Deutschland [Evaluation of the work of Drug Consumption Rooms in Germany] (Vol. 149. Nomos). Baden-Baden: Schriftenreihe des Bundesministeriums für Gesundheit und Soziale Sicherheit.
   Google Scholar
• Rhodes, T., & Hedrich, D. (2010). Harm reduction: evidence, impacts and challenges. Lisbon: EMCDDA Monographs.
   Google Scholar
• Robert Koch Institut. (2010). Epidemiologisches Bulletin [Epidemiological bulletin], Nr. 46 from 22 November.
   Google Scholar
• Schulte, B., Stöver, H., Thane, K., Schreiter, C., Gansefort, D., & Reimer, J. (2009). Substitution treatment and HCV/HIV infection in German prisons. International Journal of Prisoner Health, 5(1), 39–44.
   PubMedGoogle Scholar
• Stimson, G. (1989). Syringe-exchange programmes for injecting drug users. AIDS, 3, 253–260.
   PubMed Web of Science ®Google Scholar
• Stöver, H. (1991). Der tolerierte intravenöse Drogengebrauch in den Angeboten der Drogen- und AIDS-Hilfe: Problembereiche und Perspektiven eines konsequenten Angebots der Überlebenshilfe und des Gesundheitsschutzes [Tolerated intravenous drug consumption in facilities of drug- and AIDS-services: problematic fields and perspectives of a consistent offer for survival assistance and health protection]. In Der tolerierte intravenöse Drogengebrauch in den Angeboten der Drogen- und AIDS-Hilfe [Tolerated intranevious drug consumption in facilities of drug- and AIDS-services] (Vol. VI, pp. 9–22). Berlin: Deutsche AIDS-Hilfe, DAH-Forum.
   Google Scholar
• Stöver, H. (2002). Consumption rooms: a middle ground between health and public order concerns. In L. Böllinger, et al. (Eds.). Journal of Drug Issues, 32(2), 597–606.
   Web of Science ®Google Scholar
• Stöver, H., & Prinzleve, M. (Eds.). (2004). Kokain und Crack: Pharmakodynamiken, Hilfeangebote [Cocaine and crack: pharmacodynamics, aid services]. Freiburg: Lambertus.
   Google Scholar
• Stöver, H. (2011). Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians. European Addiction Research, 17, 44–54.
   PubMed Web of Science ®Google Scholar
• Stöver, H., Casselman, J., & Hennebel, L. C. (2006). Substitution treatment in European prisons: a study of policies and practices of substitution treatment in prisons in 18 European countries. The International Journal of Prisoner Health, 2(1), 3–12.
   Google Scholar
• Stöver, H., & Michael, P. (Eds.). (2004). Kokain und Crack: Pharmakodynamiken, Hilfeangebote [Cocaine and Crack: Pharmokodynamics, support services]. Freiburg: Lambertus.
   Google Scholar
• Stöver, H., & Nelles, J. (2003). Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy, 14(5–6), 437–444.
   Google Scholar
• Tossmann, P., Boldt, S., & Tensil, M. D. (2001). The use of drugs within the techno party scene in European metropolitan cities. European Addiction Research, 7, 2–23.
   PubMed Web of Science ®Google Scholar
• United Nations. (2002). Preventing the transmission of HIV among drug abusers: a position paper of the United Nations system. Vienna: Commission on Narcotic Drugs.
   Google Scholar
• Van den Brink, W., & Haasen, C. (2006). Evidence based treatment of opiate dependent patients. Canadian Journal of Psychiatry, 10, 635–645.
   Google Scholar
• Verthein, U., Bonorden-Kleij, K., Degkwitz, P., Dilg, C., Köhler, W.K., Passie, T., (2008). Long-term effects of heroin-assisted treatment in Germany. Addiction, 103, 960–966.
   PubMed Web of Science ®Google Scholar
• Verthein, U., Kalke, J., & Raschke, P. (1998). Substitution treatment with methadone in Germany: politics, programmes and results. International Journal of Drug Policy, 9, 71–78.
   Google Scholar
• Wittchen, H. U., Apelt, S. M., Bühringer, G., Gastpar, M., Backmund, M., Gölz, J., (2005). Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study. International Journal of Methods in Psychiatric Research, 14(1), 14–28.
   PubMed Web of Science ®Google Scholar
• Wittchen, H. U., Apelt, S. M., Soyke, Gastpar, M., Backmund, M., Gölz, J., et al. (2008). Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug and Alcohol Dependence, 95(3), 245–257.
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). (2009). Guidelines for psychosocially assisted pharmacological treatment of opioid dependence. Geneva: Author.
   Google Scholar
• WHO/UNODC/UNAIDS. (2006). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper, Geneva: Author.
   Google Scholar
• Wood, E., Tyndall, M. W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J. S. G., (2005). Do supervised injecting facilities attract higher risk injection drug users? American Journal of Preventive Medicine, 29(20), 126–130.
   PubMedGoogle Scholar